Compounds > pyrroles
Page last updated: 2024-08-18

pyrroles and Thrombotic Microangiopathies

pyrroles has been researched along with Thrombotic Microangiopathies in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Adamson, D; Buckley, FD; Meiklejohn, DJ; Preston, G1
Costero, O; Martinez-Ara, J; Picazo, ML; Romero, S; Selgas, R; Zamora, P1

Other Studies

2 other study(ies) available for pyrroles and Thrombotic Microangiopathies

ArticleYear
Sunitinib-associated thrombotic microangiopathy: a significant risk.
    Clinical oncology (Royal College of Radiologists (Great Britain)), 2014, Volume: 26, Issue:8

    Topics: Antineoplastic Agents; Clinical Trials, Phase III as Topic; Humans; Indoles; Pyrroles; Sunitinib; Thrombotic Microangiopathies

2014
Inhibition of tyrosine kinases by sunitinib associated with focal segmental glomerulosclerosis lesion in addition to thrombotic microangiopathy.
    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2010, Volume: 25, Issue:3

    Topics: Aged; Antineoplastic Agents; Biopsy; Carcinoma, Renal Cell; Enalapril; Glomerulosclerosis, Focal Segmental; Humans; Indoles; Kidney; Kidney Neoplasms; Lung Neoplasms; Male; Protein-Tyrosine Kinases; Pyrroles; Sunitinib; Thrombotic Microangiopathies

2010